Telepsychiatry to Improve the Management of Adolescent Depression in Primary Care

NCT01860443 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2016-05-17

No results posted yet for this study

Summary

Background: Depression is common in adolescents and it is associated with serious consequences. In Chile, primary care team has a leading role in the management of depression in adolescents. Nevertheless, the majority of primary care professionals report not feeling adequately prepared to take on this responsibility and having difficulties referring patients to specialists. This situation is particularity complex in regions far away from the central zone. Telepsychiatry is a potential solution to an equitable access to specialized clinical expertise.

Purpose: The purpose of this study is to determine whether a telepsychiatry-based collaborative program is effective to improve the management of depression in adolescents between 13 and 19 years of age in 16 primary care clinics in the Araucanía Region, Chile.

Study design: A cluster-randomized clinical trial will be carried out with 237 adolescents. The efficacy, adherence, and acceptability of the telepsychiatry-based collaborative program will be evaluated.

Conditions

Interventions

OTHER

Telepsychiatry collaborative program

The intervention includes: * Online training for the health staff * Medical and psychological treatment, as described in the AUGE Clinical Guidelines for Depression * Online supervision in a web platform by specialists * Telephone monitoring

OTHER

Usual care

* Online training for the health staff * Medical and psychological treatment, as described in the AUGE Clinical Guidelines for Depression

Sponsors & Collaborators

  • University of Chile

    lead OTHER

Principal Investigators

  • Vania Martínez-Nahuel, Dr.med. · University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01860443 on ClinicalTrials.gov